Treatment News : Number of HIV Regimens Linked to Lower Bone Mineral Density

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » July 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


July 9, 2013

Number of HIV Regimens Linked to Lower Bone Mineral Density

The greater the number of times people with HIV have switched antiretroviral (ARV) drug regimens, the more likely they are to have low bone mineral density (BMD), MedPage Today reports.  Researchers presented their findings from a study of 210 HIV-positive participants at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.

The study, which also included 264 HIV-negative participants who were selected because they had similar demographics to the HIV-positive group, examined various clinical measures, as well as laboratory data and medication histories. BMD was measured through an annual dual x-ray absorptiometry at the femoral neck and lumbar spine.

After a statistical analysis, the researchers found that each additional ARV regimen someone with HIV had taken during their time living with the virus, BMD loss at the neck was -0.011 grams per square centimeter. Meanwhile, the lumbar spine suffered a loss of -0.105 g/cm2.

Switching drug regimens does not necessarily cause the lowered BMD, however.  The number of regimens is itself likely correlated with increased drug toxicity, drug resistance and lower adherence to ARVs.

To read the MedPage Today story, click here.

To read the IAS abstract, click here.

Search: Bone mineral density, HIV, antiretroviral regimens, 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, IAS 2013.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.